Please assess the completion status of the following clinical trial:

Trial Title: Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Hospitalized male and female subjects with clinically documented nosocomial pneumonia proven to be due to methicillin-resistant staphylococcus aureus.~* Chest X-ray at baseline/screen or within 48 hours of treatment consistent with the diagnosis of pneumonia.~* Suitable sputum specimen defined as having less than 10 squamous epithelial cells and greater or equal 25 leukocytes or have a culture taken by an invasive technique within 24 hours of study entry.~Exclusion Criteria:~* Subjects who were treated with a previous antibiotic with MRSA activity (other than linezolid or vancomycin) for more than 48 hours, unless documented to be a treatment failure (72 hours of treatment and not responding).~* Subjects with severe neutropenia (\<500 cells/mm3)~* Subjects with hypersensitivity to oxazolidinones or vancomycin.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Subjects receiving linezolid for the treatment phase of the study
- 2 (Type: ACTIVE_COMPARATOR): Subjects receiving vancomycin for the treatment phase of the study

Based on this trial design, predict the completion outcome and termination type (if applicable).